Programme Seminars
Held every 3-4 months, these seminars showcase brain tumour research happening in Cambridge. All Neuro-oncology Programme seminars are also available as a list on the University of Cambridge's talks.cam website
| January 2022 | Tuesday 18th January, 12-1pm | Friederike Hesse | Brindle group, CRUK Cambridge Institute
“Imaging response of glioblastoma to radiotherapy using 2H MRI measurements of [2,3-2H2]fumarate metabolism” Mr Richard Mair | Dept of Clinical Neurosciences and CUH Neurosurgery “The Minderoo Precision Brain Tumour Programme” |
Online - register here |
| April 2022 | Tuesday 19th April, 12-1pm | What's new in Neuropathology?
Speakers TBC |
TBC |
| June 2022 | Tuesday 14th June, 12-1pm | What's new in Radiotherapy for brain tumours?
Speakers TBC |
TBC |
| October 2022 | Tuesday 18th October, 12-1pm | TBC | TBC |
Past Events
| October 2021 | Wed 20th October, 12-1pm | Neuro-oncology Programme Seminar
Mr Richard Mair | “Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients” Dr Omer Bayraktar | “GBM-space: Discovering how the tumour microenvironment regulates glioblastoma cell states” |
Online |
| May 2021 | Tues 28th & Wed 19th May | CRUK Cambridge Centre Neuro-oncology Conference 2021
Bringing together leading brain tumour researchers from Cambridge and the wider international community to share the latest advances in neuro-oncology. |
Online |
| April 2021 | Wednesday 14th April, 12-1pm | Neuro-oncology Programme Seminar
Mr Stephen Price | ‘Precision Surgery for Glioblastomas’ Dr Petra Hamerlik | "Functional Interplay Between Aberrant DNA Repair & Cellular Hierarchies in Glioblastoma" |
Online |
| Jan 2021 | Tues 26th January, 12-1pm | Neuro-oncology Programme Seminar
Dr Pau Creixell | "Novel approaches to therapeutically target tyrosine kinases driving brain, breast and lung cancer” Prof David Rowitch & Prof Peter Hutchinson | "Intra-operative MRI for brain tumours" |
Online |
| October 2020 | Tues 6th October 12-1pm | Neuro-oncology Programme Seminar
Dr Manav Pathania | “Developing new models of mutant histone-driven paediatric gliomas” Dr Rafa Romero Garcia | “Translating neuroimaging and connectomic findings for understanding cognitive recovery in glioma patients” |
Online |
| April 2020 | Wed 1st April 2020, 9-9.30am | Children's Brain Tumour Centre of Excellence (CBTCE) Breakfast Meeting - co-hosted by the Paediatric Cancer and Neuro-oncology Programmes at CRUK Cambridge Centre
Join Prof Richard Gilbertson over breakfast to discuss the newly launched CBTCE and discuss how this Centre will be tackling children’s brain tumours. |
Online |
| January 2020 | Tues 21st Jan 2020, 4-5pm | Neuro-oncology Programme Seminar
George Malliaras | EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers Chao Li | Characterising Heterogeneity of Glioblastoma using Multi-parametric Magnetic Resonance Imaging |
LT2, Clinical School, Cambridge Biomedical Campus |
| October 2019 | Wed 9th Oct 2019, 4-5pm | Neuro-oncology Programme Seminar Rohit Sinha | Applying Cognitive Neuroscience methods in Cancer Ana Rossi | Mechanisms linking hypoxia, type 2 IP3 receptors and invasiveness in glioma cells |
Neurosciences Seminar Room, B Spur, Cambridge Biomedical Campus |
| June 2019 | Wed 26th June 2019, 4-5pm | Neuro-oncology Programme Seminar
Raj Jena | The edge of the cloud - machine learning and mapping glioma on MR imaging Harry Bulstrode | Targeting Glioma Stem Cells using Zika Virus |
LT2, Clinical School, Cambridge Biomedical Campus |
| April 2019 | 11-12 April 2019 | Neuroblastoma UK 5th Research Symposium
Organised by Neuroblastoma UK and co-hosted by Prof Anna Philpott (Dept Oncology, University of Cambridge). One and a half days of international speakers, poster presentations and discussion on the latest in neuroblastoma research. Sponsors: The CRUK CC Paediatric Cancer Programme, the CRUK CC Neuro-oncology Programme, EUSAPharma and ErgoMed. |
Perse School, Cambridge |
Calendar
This calendar shows all internal and external events that may be of interest to brain tumour researchers and clinicians.
